KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Acadia Pharmaceuticals (ACAD) Current Leases: 2009-2012

Historic Current Leases for Acadia Pharmaceuticals (ACAD) over the last 2 years, with Sep 2012 value amounting to $3,000.

  • Acadia Pharmaceuticals' Current Leases was N/A to $3,000 in Q3 2012 from the same period last year, while for Sep 2012 it was $3,000, marking a year-over-year change of. This contributed to the annual value of $32,000 for FY2011, which is 58.97% down from last year.
  • Latest data reveals that Acadia Pharmaceuticals reported Current Leases of $3,000 as of Q3 2012, which was down 76.92% from $13,000 recorded in Q2 2012.
  • In the past 5 years, Acadia Pharmaceuticals' Current Leases ranged from a high of $685,000 in Q1 2009 and a low of $3,000 during Q3 2012.
  • Its 3-year average for Current Leases is $91,625, with a median of $61,000 in 2010.
  • Data for Acadia Pharmaceuticals' Current Leases shows a maximum YoY tumbled of 84.88% (in 2011) over the last 5 years.
  • Over the past 4 years, Acadia Pharmaceuticals' Current Leases (Quarterly) stood at $365,000 in 2009, then slumped by 78.63% to $78,000 in 2010, then crashed by 58.97% to $32,000 in 2011, then reached $3,000 in 2012.
  • Its Current Leases stands at $3,000 for Q3 2012, versus $13,000 for Q2 2012 and $32,000 for Q4 2011.